Copyright Seeking Alpha
Clorox FQ1 results top estimates despite lingering ERP-related headwinds Nov. 03, 2025 4:40 PM ETThe Clorox Company (CLX) StockBy : Amy Thielen, SA News Editor Comments (2) Clorox (CLX) shares are up in Monday’s postmarket trading as the company’s fiscal first quarter results were not as bad as Wall Street feared even as the transition to the enterprise resource planning (ERP) platform continued to weigh on profitability. At Quick Insights The ERP transition led to shipment declines, lower sales, gross margin compression, and a decrease in operational cash flow due to inventory timing and fulfillment challenges. Clorox expects net sales to decline 6-10% and adjusted earnings to decrease 18-23%, with sales projected between $6.39B and $6.67B and earnings per share of $5.95 to $6.30. Health and Wellness and Household segments saw 19% declines each, while the Lifestyle segment sales dropped by 23%. Recommended For You
